Patients With Cervical Cancer Should Explore Their Fertility Options

News
Video

Cervical cancer survival and Cervivor ambassador Kate Weissman provides advice on conversations patients with cervical cancer should be having with their care teams.

When receiving a diagnosis of cervical cancer, patients should discuss their fertility options with their care team and be attuned to their mental and emotional well-being, as a survivor and advocate Kate Weissman told CURE®.

“You need to understand and advocate for yourself (and say), ‘Look, this is something that I want to do in my life. This is something I want to have options for in my life. So, what can we do?’ If the answer is ‘Absolutely not,’ then that's a situation where mental health resources really need to come into play,” Weissman advised.

Weismann received a diagnosis of stage 2B cervical cancer in 2015 at the age of 30, two years after being diagnosed with HPV, she was also told by her oncologist that she would not be able to carry children. She began IVF, froze nine embryos and received treatment via 55 rounds of radiation, 17 rounds of chemotherapy and surgery before being declared cancer-free in 2016. She and her husband, Matt, eventually had a daughter, Louella, via surrogacy.

Weissman is now an ambassador for Cervivor, a community of patient advocates working with those affected by cervical cancer, and a 2023 Cervivor Champion Recipient, as well as the Massachusetts State Lead Ambassador for the American Cancer Society Cancer Action Network.

Learn more: Expert Offers 3 Ways to Be a Self-Advocate During Cancer Treatment

She spoke with CURE® about what conversations patients should be having with their care teams after receiving a diagnosis of cervical cancer.

Transcription:

It has to be: What are my options? And you need to understand and advocate for yourself, ‘Look, this is something that I want to do in my life. This is something I want to have options for in my life. So, what can we do?’ If the answer is ‘Absolutely not,’ then that's a situation where mental health resources really need to come into play.

I think a lot of people are just so focused on curing the cancer, which of course is the number one priority, but we also need to make sure that we're unpacking for women what they're also mourning the loss of while they are going through this really difficult time and scary time of their life. So, we need to also make sure that mental health resources are deployed for women.

And I really advise everyone to explore your options, but also to make sure that you're researching different grants that you can apply for because having a baby in a non-traditional way is extremely expensive, no matter which route you go — surrogacy, adoption, egg donors, any of the above, they're really expensive. And it also depends on what state you live in, what's going to be covered and not covered for you.

So, I recommend people start to explore any grant opportunities, do a GoFundMe, figure out how financially you're going to cover this too, if it's a goal of yours, because it's going to be expensive.

This transcript has been edited for clarity.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE